University of Tennessee Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Tennessee Medical Center sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
University of Tennessee Medical Center: 4 sponsored US clinical trials, 2 recruiting.
University of Tennessee Medical Center sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Nephrolithotomy, Percutaneous, with 1 trials.
Upper-quartile sponsor footprint
University of Tennessee Medical Center sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Sensory-Evoked Cortical Gamma Oscillation
NCT05206305
ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy
NCT05024344
HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients
NCT03710187
Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome
NCT03670160
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Therapeutic Areas
What is open in the University of Tennessee Medical Center pipeline
2 recruiting of 4 indexed (50% open); 2 completed (50%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Nephrolithotomy, Percutaneous (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Tennessee Medical Center: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
University of Tennessee Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this University of Tennessee Medical Center page
4 registered trials is a research-attention snapshot, not an endorsement of University of Tennessee Medical Center or any single study.
- 2 of University of Tennessee Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Nephrolithotomy, Percutaneous is the condition University of Tennessee Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Nephrolithotomy, Percutaneous trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Tennessee Medical Center pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.